CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 113 enrolled
Drug / intervention
ketamine infusion +1 moredrug
Likely dose
ketamine infusion 5mcg/Kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01594047
NCT01594047N/ACompleted

Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano·interventional·Posted May 8, 2012·Updated Oct 1, 2025

In Brief

A clinical study evaluating ketamine infusion and Methadone PCA for Post Operative Pain and Hyperalgesia. Completed, enrolled 113 participants across 1 site.

Detailed Summary

Background: In perioperative period inhibition of N-Methyl-D-Aspartate receptor prevents opioid-induced hyperalgesia and reduce postoperative opioid requirement after abdominal surgery. Methadone is both a µ-opioid receptor agonist like Morphine and a N-Methyl-D-Aspartate antagonist. Study Aim. To evaluate the efficacy of intraoperative Ketamine and postoperative Methadone analgesia in preventing opioid-induced hyperalgesia after abdominal surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMay 8, 2012
Enrollment StartDec 1, 2009
Primary CompletionJun 1, 2012
Study CompletionAug 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 14.2 years ago

Interventions

ketamine infusiondrug

Ketamine infusion scheme: 5mcg/Kg/min from induction od anaesthesia for 10 min, than 2,5mcg/Kg/min for 20 min and than 2 mcg/Kg/min to the end of surgery

Methadone PCAdrug

Methadone administered by a PCA system (dose 2 mg, lock-out 12min.)